Voyager Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.About VYGR
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.
CEOAlfred W. Sandrock
CEOAlfred W. Sandrock
Employees172
Employees172
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2013
Founded2013
Employees172
Employees172
VYGR Key Statistics
Market cap232.41M
Market cap232.41M
Price-Earnings ratio-1.90
Price-Earnings ratio-1.90
Dividend yield—
Dividend yield—
Average volume400.74K
Average volume400.74K
High today$4.19
High today$4.19
Low today$4.12
Low today$4.12
Open price$4.12
Open price$4.12
Volume30.03K
Volume30.03K
52 Week high$6.27
52 Week high$6.27
52 Week low$2.65
52 Week low$2.65
Stock Snapshot
The current Voyager Therapeutics(VYGR) stock price is $4.18, with a market capitalization of 232.41M. The stock trades at a price-to-earnings (P/E) ratio of -1.90.
During the trading session on 2025-12-19, Voyager Therapeutics(VYGR) shares reached a daily high of $4.19 and a low of $4.12. At a current price of $4.18, the stock is +1.5% higher than the low and still -0.2% under the high.
Trading volume for Voyager Therapeutics(VYGR) stock has reached 30.03K, versus its average volume of 400.74K.
Over the past 52 weeks, Voyager Therapeutics(VYGR) stock has traded between a high of $6.27 and a low of $2.65.
Over the past 52 weeks, Voyager Therapeutics(VYGR) stock has traded between a high of $6.27 and a low of $2.65.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own VYGR. This list is generated using Robinhood data, and it’s not a recommendation.